RxDoctor Payments Data

Rakesh Chawla, MD

Interventional Cardiology · Englewood, OHNPI 1023082278

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) at 51.4% of the total. 2025 is the largest year on record at $379, more than ten times the $31 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in OH, where the typical reported total is $4,547.

$538in general payments, 2019–2025

Across 13 payments — averaging $41.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$276
  • Boston Scientific$139
  • Shockwave Medical, Inc$36
  • Abbott$22
  • Abiomed$18
  • Cook Medical LLC$16
  • plus $31 from 2 others

What the payments were for

  • Grants$163%
  • Food & beverage$52297%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$538 in reported general payments places this provider in the 10th percentile of 256 interventional cardiology providers in Ohio.

See all interventional cardiology providers in Ohio →

Medicare billing

Part B allowed, 2024
$60,932
Medicare patients
831
Services billed
1,567

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide38$54,324
MounjaroTirzepatide13$13,628
EntrestoSacubitril/Valsartan13$13,626
XareltoRivaroxaban13$8,715
Atorvastatin Calcium69$714
ClopidogrelClopidogrel Bisulfate49$482
Isosorbide Mononitrate ErIsosorbide Mononitrate20$351
Metoprolol Succinate30$328
Spironolactone33$288
Furosemide32$185
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide11$177
Rosuvastatin Calcium11$148
Losartan Potassium13$93
Amlodipine Besylate12$55
Metformin Hcl13$48

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Englewood

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →